In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells by Paquette, B et al.
In vitro irradiation of basement membrane enhances the
invasiveness of breast cancer cells
B Paquette*,1,2, C Baptiste
1, H Therriault
1,2, G Arguin
3, B Plouffe
4 and R Lemay
1,2
1Department of nuclear medicine and radiobiology, Faculty of medicine and health sciences, Universite ´ de Sherbrooke, 3001 12th Avenue North,
Sherbrooke, Que ´bec, Canada;
2Centre de recherche en radiothe ´rapie, CRC-E ´tienne LeBel, Centre Hospitalier Universitaire de Sherbrooke, 3001 12th
Avenue North, Sherbrooke, Que ´bec, Canada;
3Department of pharmacology, Faculty of medicine and health sciences, Universite ´ de Sherbrooke, 3001
12th Avenue North, Sherbrooke, Que ´bec, Canada J1H 5N4;
4Ottawa Health Research Institute, Moses and Rose Loeb Research Centre, 725 Parkdale
Avenue, Ottawa, Ontario, Canada K1Y 4E9
Following removal of the primary breast tumour by conservative surgery, patients may still have additional malignant foci scattered
throughout the breast. Radiation treatments are not designed to eliminate all these residual cancer cells. Rather, the radiation dose is
calculated to optimise long-term results with minimal complications. In a tumour, cancer cells are surrounded by a basement
membrane, which plays an important role in the regulation of gene expression. Using an invasion chamber, we have shown that
irradiation before cell plating of a reconstituted basement membrane (Matrigel; Becton Dickinson, Bedford, MA, USA) increased the
invasiveness of the breast cancer cells MDA-MB-231. This radiation enhancement of invasion was associated with the upregulation of
the pro-invasive gene matrix metalloproteinase (MMP)-2. The expression of membrane type 1 matrix metalloproteinase (MT1-
MMP) and tissue inhibitor of metalloproteinase-2 (TIMP), which are required to activate the MMP-2, were also increased. Confirming
the role of MMP-2 and MT1-MMP, radiation enhancement of cancer cell invasion was prevented by an MMP-2 inhibitor and an anti-
MT1-MMP antibody. This study also demonstrated that radiation can potentially enhance the invasion ability by inducing the release
of pro-invasive factors stored in the Matrigel. Conversely, no enhancement of invasiveness was observed with the low metastatic cell
line MCF-7. This lack of invasiveness correlated with the absence of the MMP-2 activator MT1-MMP in the MCF-7 cells. Radiotherapy
is an efficient modality to treat breast cancer which could be further improved by inhibiting the pro-invasive gene upregulated by
radiation.
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The efficiency of radiotherapy to treat breast cancer is well
established (Clarke et al, 2005). However, the radiation dose used
in the clinic (50–60Gy) is not calculated to eliminate all cancer
cells scattered throughout the breast but rather to optimise long-
term results with minimal complications. The three major normal
tissue side-effects are cosmetic outcome, cardiac complications
and pulmonary fibrosis (Coles et al, 2005). The principal long-term
complications that impair cosmetics are fibrosis and induration of
the breast resulting from inflammatory responses induced by
radiation (Archambeau et al, 1995). The probability of observing
late changes by 5 years for patients receiving radiotherapy is about
40% (Coles et al, 2005).
Following surgery both surgeons and patients are reassured by
histological confirmation of complete excision, with clear margins.
However, several reports have questioned the accuracy of patholo-
gical assessment (Holland et al, 1985; Frazier et al, 1989; Silverstein
et al, 1994). In a detailed analysis of mastectomy specimens, it has
been shown that malignant foci were found at a distance of 2cm
from tumour edge in 42% of specimens (Holland et al,1 9 8 5 ) .A n
other team has reported that residual cancer cells were observed in
as many as 26% of patients reported to have pathological margins
clear of tumour (Frazier et al, 1989). Of patients clinically and
mammographically suspected of having unifocal breast cancer,
39–63% will have additional malignant foci in the ipsilateral breast
as determined by detailed serial sectioning of the mastectomy
specimen (Lagios et al, 1981; Holland et al, 1985).
Consequently, a number of breast cancer cells are not eliminated
after surgery and radiotherapy. These residual cancer cells could
be responsible for distant metastases associated with death from
breast cancer. The overall aim of this study is to determine whether
ionising radiation could enhance the invasion capacity of the
breast cancer cells that are not eliminated after therapy.
A breast tumour can be divided into five parts: cancer cells,
fibroblast, inflammatory cells, blood vessels and the basement
membrane. In this study, we want to determine whether
irradiation of basement membrane could enhance the invasion
ability of breast cancer cells. Basement membrane acts as a barrier
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sto cancer cell invasion. To overcome this barrier, advancing cells
express proteinases and/or proteinase activators at their leading
edge, where complex proteolysis can direct cell migration. Among
these proteinases, matrix metalloproteinases (MMPs) are believed
to play a major role in tumour invasion since they can degrade
almost all the basement membrane macromolecules (Rooprai and
McCormick 1997; Fillmore et al, 2001).
Matrix metalloproteinase-2 plays a major role in the proteolysis
of basement membrane and is associated with tumour invasion
and metastasis (Gilles et al, 1998; Jones et al, 1999). Matrix
metalloproteinase-2 is released by cancer cells or fibroblasts under
an inactive form called proMMP-2 (Liotta and Stetler-Stevenson
1991; Belkhiri et al, 1997). Activation of proMMP-2 requires the
contribution of a cell membrane MMP (ie membrane type 1 MMP,
MT1-MMP) and the tissue inhibitor of metalloproteinase-2 (TIMP-
2). The catalytic domain of MT1-MMP binds to the N-terminal
portion of TIMP-2, leaving the negatively charged C-terminal
region of TIMP-2 available for binding to the hemopexin-like
domain of proMMP-2 (Zucker et al, 1998). This ternary complex
clusters proMMP-2 near a TIMP-2-free MT1-MMP molecule on the
cell surface. Free MT1-MMP cleaves the prodomain of proMMP-2
thus generating the 64-kDa activation intermediate that then binds
to avb3 integrin and matures into the fully active 62-kDa MMP-2.
Localisation of active MMP-2 and avb3 integrin at the migration
front accelerates cancer cell migration (Brooks et al, 1996;
Deryugina et al, 2001).
Basement membrane stores pro-invasive factors such as insulin-
like growth factor (IGF), epidermal growth factor (EGF) and basic
fibroblast growth factor (bFGF) which can stimulate the expression
of MMP-2 and other MMPs (Mira et al, 1999; Zhang and Brodt
2003; Lee et al, 2004). Injuries to the basement membrane can
result in the release of these pro-invasive compounds. Further-
more, fragmentation of matrix proteins by free radicals or limited
proteolysis can generate biologically active peptides, that is, the
matrikines (Vartio 1989; Monboisse and Borel 1992; Raats et al,
1997; Duca et al, 2004). Once released, these matrikines, such as
elastin peptides, can increase the expression of MMP-2, MT1-MMP
and TIMP-2 in fibrosarcoma HT-1080 cells (Brassart et al, 1998).
Matrikines can also be derived from laminins, proteoglycans or
collagens (Pasco et al, 2004).
In this study, we have determined whether irradiation of a
reconstituted basement membrane (Matrigel; Becton Dickinson,
Bedford, MA, USA) could enhance the expression of MMP-2, MT1-
MMP and TIMP-2 from breast cancer cells. Invasion chambers
coated with Matrigel were irradiated prior to plate breast cancer
cells and then the invasiveness of a highly metastatic breast
carcinoma cell line, the MDA-MB-231 cells and of a weakly
metastatic one, the MCF-7 cells were determined.
MATERIALS AND METHODS
Chemicals and reagents
p-Aminophenylmercuric acetate (APMA), Cell Dissociation Solu-
tion, diethyl pyrocarbonate (DEPC), DNase and gelatine were
purchased from Sigma-Aldrich Canada Ltd (Oakville, Ontario,
Canada). (2R)-[(4-biphenylylsulfonyl)amino]-N-hydroxy-3-phe-
nylpropionamide, fluorogenic peptide MMP Substrate III,
proMMP-2 and -9 were obtained from Calbiochem (San Diego,
CA, USA). Matrigel (standard growth factors), invasion chambers
and Cell Recovery Solution were obtained from BD Biosciences
(Oakville, Ontario, Canada).
Mammary cells culture
The MDA-MB-231 and MCF-7 human breast cancer lines were
obtained from American Type Culture Collection. Culture medium
consisted of minimum essential medium (MEM) containing
phenol red (Sigma, A-6770) and supplemented with 10% fetal
bovine serum (FBS), penicillin (10Uml
 1), streptomycin
(10mgml
 1), amphotericin B (0.25mgml
 1), L-glutamine (2mM)
and sodium pyruvate (1mM).
Irradiation of Matrigel
A volume of 500ml of Matrigel diluted in MEM medium without
FBS at a final concentration of 5mgml
 1 was added in six-well
plate and allowed to polymerise for 1h at 371C. Matrigel covered
by 0.5ml of phosphate-buffered saline (PBS) was irradiated using
the
60Co source (Gammacell 220, Nordion, Canada) at the dose
indicated. Non-irradiated Matrigel was used as control.
RNA isolation
Breast cancer cells were plated on either irradiated or non-
irradiated Matrigel and incubated for 24h in FBS-free culture
medium. Cells were isolated with 1ml Cell Recovery Solution
(Sigma) incubated at room temperature for 10min. Total RNA was
isolated using the RNeasy Mini kit (QIAGEN, Mississauga,
Canada) and then quantified in DEPC-treated water with a
spectrophotometer. To reduce non-specific amplification, RNA
samples were treated with the Amplification Grade DNase I kit
(Sigma, Oakville, ON, Canada). Briefly, 1mg of RNA diluted in 8ml
DEPC water was treated with 1ml Amplification Grade DNase I
(1Uml
 1) in a final volume of 10ml completed with the reaction
buffer (20mM Tris-HCl pH 7.5, 1mM CaClB2). After 15min
incubation at room temperature, 1ml of the Stop solution (50mM
EDTA) was added. The RNA samples were then heated at 701C for
10min to denature the DNase I.
Real-time PCR
cDNA was produced from the DNase I-treated RNA samples by
adding to 1mg RNA, the reverse transcriptase M-MLV (200U per
21ml) (Bio Can Scientific Inc., Mississauga, ON, Canada), the
RNase inhibitor RNAguardt (2U per 21ml) (Amersham Bios-
ciences, Baie d’Urfe, Que ´bec, Canada), the pd(N)6 (100pmolml
 1)
and the dNTPS (10mM) (Amersham Pharmacia Biotech Inc.,
Piscataway, NJ, USA) in a final volume of 21ml completed with the
reaction buffer (final concentrations: 50mM Tris-HCl pH 8.3,
75mM KCl, 3mM Mgcl2,1 0 m M dithiothreitol). The reaction
conditions were 201C for 10min, 421C for 50min and 951C for
5min.
A total of 50ng of the cDNA product was used for real-time
PCR. Amplification of each PCR product was carried out
separately in a different tube. The primers used were MMP-2
(71pb) sense primer 50-CGCTCAGATCCGTGGTGAG-30, antisense
primer 50-TTGTCACGTGGCGTCACAG-30 (Strup-Perrot et al,
2004); MT1-MMP (496pb) sense primer, 50-CGCTACGCCATCCAG
GGTCTCAAA-30, antisense primer 50-CGGTCATCATCGGGCAG-
CACAAAA-30 (Daja et al, 2003); TIMP-2 (303pb) sense primer 50-
GGTCTCGCTGGACGTTGGAG-30, antisense primer 50-GGAGCCG
TCACTTCTCTTG-30 (Balduyck et al, 2000). As control, glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) (307pb) amplifi-
cation was performed using the primers: sense 50-CGGAGTCAACG
GATTTGGTCGTAT-30, antisense 50-AGCCTTCTCCATGGTGGTG
AAGAC-30 (Wong et al, 2001).
Real-time PCR were performed using the detection kit
Quantitectt SYBR
s Green PCR
s (QIAGEN) under the following
conditions. Reaction mixtures with primers at 10pmolml
 1 were
incubated in the thermocycler LightCycler (Roche Applied Science,
Laval, Que ´bec, Canada). All PCR programs started with 15min at
951C to activate the HotStarTaq
s DNA polymerase. The specific
conditions were MMP-2, 30s at 941C, 45s at 521C and 1min at
721C; MT1-MMP, 30s at 941C, 30s at 621C and 1min at 721C;
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Amplifications were performed for a maximum of 45 cycles.
Relative quantification was performed with the LightCycler
s
Software 4.0 according to the manufacturer’s instructions and
the method reported by Pfaffl (2001). Fusion curves were
performed to eliminate the possibility of quantifying non-specific
sequences. The PCR products were also analysed on 1.8% agarose
gels to confirm that the right amplifications had been effectuated.
DNA bands were stained with the fluorogen SYBR Green IP
sP
P(Molecular Probes, Burlington, Ontario, Canada) and analysed at
500nm with the STORM
s 860 and the software ImagQuantt
(Molecular Dynamics Inc., Baie d’Urfe, Que ´bec, Canada).
Secretion of MMP-2 from cancer cells plated on irradiated
Matrigel
A volume of 500ml of Matrigel diluted in an MEM medium without
FBS at a final concentration of 5mgml
 1 was added to the six-well
plate and allowed to polymerise for 1h at 371C. Matrigel covered
by 0.5ml of PBS was irradiated using the
60Co source (Gammacell
220, Nordion) at a dose of 20Gy. Non-irradiated Matrigel was used
as control. MDA-MB-231 or MCF-7 breast cancer cells (6 10
5)
were added on Matrigel in 10% FBS MEM and incubated for 3h.
Then the cells were washed twice using PBS, and incubated for 24h
in FBS-free culture medium. Conditioned media were obtained
using FBS-free culture medium to eliminate the endogenous
proMMPs found in FBS. The conditioned media were concentrated
20 times using the Centricon YM30 column (Millipore, Etobicoke,
Ontario, Canada) and samples were then analysed on a zymo-
graphy gel as previously described (Paquette et al, 2005).
Zymography is a non-reducing acrylamide gel polymerised with
an MMP-2 and MMP-9 Substrate, gelatine. It allows proMMP and
MMP to be distinguished according to their molecular weights.
Samples were applied on a 12% polyacrylamide-sodium dodecyl
sulfate (SDS) gel containing 0.1% gelatine and electrophoresed at
150V during 3h at 41C. After removal of SDS from the gel by
incubating in 2.5% Triton X-100 (30min, four times), the gel was
incubated at 371C for 18h in 40mM Tris-HCl, pH 7.5, containing
10mM CaCl2,1mM ZnCl2, 200mM NaCl and stained with Coomassie
blue R-250 (Albini et al, 1995). As positive control, MMP-2 and -9
obtained from Calbiochem were activated with 1mM APMA as
previously described (Paquette et al, 2003) and analysed by
zymography. Briefly, 17ng of proMMPs were incubated in 10mlo f
buffer A (100mM Tris-HCl pH 7.6, 150mM NaCl, 5mM Cacl2,1mM
Zncl2, 0.01% Brij 35) containing 1mM APMA at 371C for 2h. A
stock solution of 10mM APMA was prepared in 0.1 N NaOH. MMPs
activated by APMA were diluted 1:8 and then electrophoresed.
Gels were scanned and analysed using ImageJ 1.34n (public
domain Java image, NIH, Bethesda, MD, USA).
Invasion chambers
Invasion chambers coated with Matrigel were rehydrated with 1ml
MEM 0.1%. bovine serum albumin (BSA) for 1h at 371C. Before
cell plating, the chambers were irradiated at the indicated dose
using a
60Co source (Gammacell 220, Nordion). MDA-MB-231 and
MCF-7 breast cancer cells were harvested with 1ml of Cell
Dissociation Solution (Sigma) incubated for 10min at room
temperature, washed with PBS, suspended in 1ml MEM 0.1%
BSA, plated (1 10
4 or 4 10
4 in 0.5ml) in the invasion chambers
and then incubated at 371C for 6h. In another series, breast cancer
cells were treated in the invasion chambers with 0.1mM of the
MMP-2 inhibitor (2R)-[(4-biphenylylsulfonyl)amino]-N-hydroxy-
3-phenylpropionamide. To determine the role of MT1-MMP,
breast cancer cells were mixed with an anti-MT1-MMP antibody
(Fitzgerald Industries International Inc., catalogue no. RDI-
MMP14 HABR) at 20mgml
 1 before plating in irradiated invasion
chambers. As chemoattractant, MEM medium supplemented with
10% FBS was added in the lower compartment of the invasion
chamber. Cells, which have crossed the Matrigel and the porous
membrane, were fixed, stained with 0.5% crystal violet and
counted under the microscope.
To determine whether the enhancement of breast cancer cell
invasion was caused by invasion factors released from irradiated
Matrigel, four conditions were tested: (1) invasion through
unirradiated Matrigel; (2) invasion through Matrigel which was
irradiated without a layer of PBS before cell plating; (3) invasion
through Matrigel which was irradiated with a layer of PBS (0.2ml)
before cell plating and (4) invasion through unirradiated Matrigel
where 0.2ml of conditioned PBS, isolated from an irradiated
invasion chamber was added. This latter conditioned PBS covered
the Matrigel of an invasion chamber during the irradiation. For the
conditions 1 and 2, 0.2ml PBS was added just before cells plating.
Irradiation of proMMP-2
Cancer cells release inactive proMMP-2 which can be activated by
free radicals, such as produced by the radiolysis of water (Saari
et al, 1992; Paquette et al, 2003). To determine whether radiation
could activate proMMP-2, aliquots (0.17mg) of this protease
(Calbiochem) were irradiated using a
60Co source (Gammacell 220,
Nordion) to a final dose of 20Gy in the buffer used for the
enzymatic assay. Conversion from proMMP-2 to active MMP-2
was monitored according to the cleavage of a fluorogenic peptide.
Briefly, irradiated proMMP-2 was mixed in the reaction buffer A
(50mM borate pH 7.4, 5mM CaCl2, 20% glycerol, 0.005% Brij,
0.01mM ZnCl2) to a final volume of 20ml. The samples were then
incubated with 50mM of the fluorogenic peptide MMP Substrate III
(Calbiochem). The enzymatic activity was recorded according to
the variation of RFU per sec. Care was taken to always work at the
saturated concentration of the fluorogenic peptide. The kinetics of
peptide cleavage were then followed for 30min using the 96-well
plate reader Synergy HT (BioTek Instruments, Winooski, VT,
USA) set at a lex¼340nm and a lem¼485nm. As a positive
control, proMMP-2 was activated with 1mM APMA as previously
described (Paquette et al, 2003).
MMP-2 activity from breast cancer cells surface
MMP-2 activity on MDA-MB-231 and MCF-7 cells plated on
irradiated Matrigel was measured using the fluorogenic peptide
MMP Substrate III. Matrigel was irradiated at 20Gy and then the
breast cancer cells were plated and incubated for 18h at 371C. The
MEM 0.1% BSA was replaced by the enzymatic buffer A and the
MMP-2 activity was measured by adding the fluorogenic peptide as
previously described in the section ‘Irradiation of proMMP-2’.
Statistical analysis
Data are expressed as the mean±standard deviation and analysed
using a Student’s t-test by comparing the experimental value to the
non-irradiated control.
RESULTS
Irradiated Matrigel enhances the expression of MMP-2,
MT1-MMP and TIMP-2
The coordinate expression of MMP-2, MT1-MMP and TIMP-2 is
required for the activation of proMMP-2. A zymography gel was
performed to determine whether irradiation of Matrigel (recon-
stituted basement membrane) can increase the secretion of MMP-2
from breast cancer cells. Petri dishes coated with Matrigel were
irradiated at 20Gy using a
60Co irradiator. Two cell lines were
tested: the MDA-MB-231 cells which are highly metastatic and the
weakly metastatic MCF-7 cells. They were plated on Petri dishes
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safter irradiation of Matrigel. The conditioned media were
harvested 24h later and MMP-2 was quantified by zymography
gel. As a control, breast cancer cells were plated on non-irradiated
Matrigel.
As shown in Figure 1A, irradiation of Matrigel at 20Gy increased
by about fourfold the level of proMMP-2 released into the culture
media by MDA-MB-231 and MCF-7 breast cancer cells, compared
to the non-irradiated controls. Conversely, the quantity of MMP-9
secreted under these conditions was negligible (Figure 1A).
Since proMMP-2 can be stored in Matrigel, the zymography was
repeated to determine whether ionising radiation could induce the
release of proMMP-2 from Matrigel. Our results showed that very
few proMMP-2 was stored in Matrigel and radiation at 20Gy
resulted in only a slight increase of proMMP-2 released (Figure 1B
lane 3 vs 4). This data also confirmed that proMMP-2 was absent
from the FBS-free culture media (Figure 1B, lane 2).
ProMMP-2 is activated on the surface of breast cancer cells by
the MT1-MMP and TIMP-2. Their corresponding mRNA expressed
by MDA-MB-231 and MCF-7 cells was quantified using a real-time
PCR assay (Table 1). The expression of both MT1-MMP and TIMP-
2 by MDA-MB-231 cells plated on irradiated Matrigel were
significantly increased by 3.07-fold and 1.59-fold, respectively.
Conversely, MT1-MMP was not detectable in the weakly metastatic
cells MCF-7, while the level of TIMP-2 was not significantly
increased by the irradiated Matrigel. Regarding the MMP-2, its
expression was stimulated in both cell lines plated on irradiated
Matrigel, supporting the results obtained with the zymography
analysis.
Enhancement of MDA-MB-231 cells invasion capacity
Invasion chambers were then used to determine whether irradiation
of Matrigel can increase the invasiveness of breast cancer cells.
Invasion chambers contain an 8mm pore-size membrane coated
with Matrigel. MMPs can digest the Matrigel, which allows the
invasion of cancer cells through the other side of the porous
membrane. Prior to the addition of breast cancer cells, invasion
chambers were irradiated using a
60Co source at the dose indicated.
Results shown in Figure 2 were normalised according to the
number of cells, which have crossed the Matrigel layer in absence
of radiation. Our data demonstrated that irradiation of Matrigel at
a dose as low as 5Gy markedly increased the invasiveness of MDA-
MB-231 cells (Figure 2A). An enhancement of 7.5-fold was
measured when the MDA-MB-231 cells were added at a
concentration of 4 10
4 per 0.5ml. At radiation doses higher
than 5Gy, the number of cells crossing the Matrigel layer was too
large to be accurately counted. Conversely, no enhancement of
invasion following Matrigel irradiation was observed for the
weakly metastatic MCF-7 cells.
To determine the effect of higher radiation dose on the
invasiveness of breast cancer cells, the assay was repeated at a
lower concentration of cancer cells, that is, 1 10
4 cells per 0.5ml
A
B
Dose (Gy)
 APMA  –– +  0   20  0 20   +    APMA 
 MCF-7  MDA-MB-231 
1    2  3 4 
proMMP-2 
MMP-2 
proMMP-9
MMP-9 
proMMP-2
MMP-2  
Figure 1 Irradiated Matrigel increased the secretion of matrix
metalloproteinase (MMP)-2 from MDA-MB-231 and MCF-7 breast cancer
cells. (A) Cancer cells (6 10
5) were added on a layer of Matrigel which
was previously irradiated using a
60Co source at 20Gy. Non-irradiated
Matrigel was used as control. After 24h incubation, the culture media was
removed, concentrated and analysed by zymogram electrophoresis gel. As
controls, proMMP-2 and -9 obtained from Calbiochem were activated with
p-aminophenylmercuric acetate (APMA) and the activated and unactivated
forms were added to the zymogram gel. (B) MMP-2 released from Matrigel
following irradiation. (1) proMMP-2 activated by APMA; (2) concentrated
FBS-free culture media; (3) concentrated FBS-free culture media incubated
for 24h on non-irradiated Matrigel; and (4) concentrated FBS-free culture
media incubated for 24h on Matrigel previously irradiated at 20Gy. These
assays were repeated four times.
Table 1 Effects of irradiated Matrigel on MMP-2, MT1-MMP and TIMP-2
expression
Enhancement ratio (20Gy per 0Gy
a)
MDA-MB-231 MCF-7
MMP-2 3.90 (±0.28)* 1.58 (±0.16)*
MT1-MMP 3.07 (±0.11)* ND
TIMP-2 1.59 (±0.30)* 1.40 (±0.30)
aThe levels of mRNA were normalized according to the internal standard GAPDH.
The enhancement ratio was calculated by dividing the normalized level measured at
20Gy by the level at 0Gy. Data represent the average of 4–6 assays±standard
deviation. MMP-2¼matrix metalloproteinase-2; MT1-MMP¼membrane type 1
matrix metalloproteinase; TIMP-2¼tissue inhibitor of metalloproteinase-2;
ND¼not detected. *n¼4-6. Po0.05.
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Figure 2 Enhancement of invasiveness induced by ionising radiation. Matrigel coated in the invasion chambers was irradiated using a
60Co source. MDA-
MB-231 and MCF-7 cells (A:4 10
4 or B:1 10
4) were added on the Matrigel after the irradiation and then incubated for 6h in MEM 0.1% BSA. MDA-
MB-231 cells: *n¼4; 0 vs 5Gy: P¼0.05; 0 vs 20Gy: P¼0.0004.
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s(Figure 2B). At a radiation dose of 5Gy, the invasion of MDA-MB-
231 cells still increased by about twofold, while an enhancement of
8.5-fold was obtained following an irradiation at 20Gy. The higher
enhancement of radiation-induced invasion at 5Gy observed after
plating 4 10
4 compared to 1 10
4 cells was suggested to be
associated with a higher quantity of MMP-2 secreted by the MDA-
MB-231 cells. As previously measured, the enhancement of
invasiveness was observed only with the MDA-MB-231 cells since
irradiation of Matrigel did not modify the invasion capacity of the
low metastatic MCF-7 cells.
The real-time PCR assay has demonstrated that irradiated
Matrigel increased the expression of MMP-2 and MT1-MMP. To
further investigate the role of theses MMPs in radiation enhance-
ment of invasion, the invasion assay was repeated in presence of
either an MMP-2 inhibitor, the (2R)-[(4-biphenylylsulfonyl)ami-
no]-N-hydroxy-3-phenylpropionamide or an anti-MT1-MMP anti-
body (20mgml
 1). As shown in Figure 3, both the MMP-2 inhibitor
and anti-MT1-MMP antibody significantly prevented the enhance-
ment of MDA-MB-231 cells invasion induced by ionising radiation.
Release of pro-invasive factors from irradiated Matrigel
Some modifications to Matrigel can be produced by the direct
interaction of radiation with Matrigel. On the other hand, the
radiolysis of water generates free radicals, which can also damage
the Matrigel. To determine the importance of these pathways,
invasion chambers were irradiated with or without a layer of PBS
added on the Matrigel. As seen in Table 2, irradiation of invasion
chambers without PBS has increased by fourfold the number of
MDA-MB-231 cells that have crossed the Matrigel, compared to
data obtained with non-irradiated invasion chambers (condition
no. 1 vs 2). This enhancement of the invasiveness of the breast
cancer cells was further increased when the invasion chambers
were covered by a layer of PBS during exposure to radiation, that
is, an 8.5-fold increase compared to non-irradiated control
(condition no. 1 vs 3). These data suggest that ionising radiation
does induce some modification of the Matrigel, which enhances
the invasiveness of MDA-MB-231 cells.
The invasion assay was then repeated to determine whether pro-
invasive factors stored in the Matrigel could be released by the
ionising radiation. To verify this hypothesis, invasion chambers
covered by a layer of PBS were irradiated. These conditioned PBS
were then transferred to new invasion chambers, where MDA-MB-
231 cells were then added (condition no. 4). As seen in Table 2,
conditioned PBS isolated from irradiated Matrigel increased by
more than eightfold the number of MDA-MB-231 cells that have
crossed the Matrigel compared to non-irradiated invasion
chambers (condition no. 1 vs 4). These data suggest that ionising
radiation can induce the release of pro-invasive factors stored in
Matrigel, which can enhance the invasiveness of MDA-MB-231
breast cancer cells.
Enhancement of MMP-2 activity on breast cancer cells
surface
Irradiated Matrigel increases the expression of MMP-2 as shown
by an enhancement of its mRNA and the release of proMMP-2
protein in culture media. We have also determined whether the
activity of MMP-2 on the cell membrane of MDA-MB-231 and
MCF-7 cells was also increased. The two cell lines were plated on
irradiated Matrigel and incubated for 18h. A fluorogenic peptide
cleaved by MMP-2 was then added. Our data demonstrate that
irradiation of Matrigel leads to a 4.5-fold increase of MMP-2
activity on the surface of MDA-MB-231 cells, while no MMP-2
activity was measured on the MCF-7 cells (Figure 4).
Radiation alone did not convert proMMP-2 into active
MMP-2
Radiolysis of water by ionising radiation generates the free radicals
O2
  and
 OH. Studies in our laboratory and elsewhere have shown
that these free radicals can convert proMMP-2 into active MMP-2
(Saari et al, 1992; Paquette et al, 2003). Therefore, assays were
carried out to determine whether ionising radiation at a dose of
20Gy could lead to the activation of proMMP-2. The level of MMP-
2 activation was determined using a fluorogenic peptide. In
parallel, MMP-2 activated by APMA was used as a positive control.
As shown in Figure 5A, a dose of 20Gy did not lead to a
detectable activation of proMMP-2. The enzymatic assay was
working, as determined after activation of proMMP-2 by the
activator APMA. To rule out the possibility that radiation might
degrade MMP-2 after the cleavage of the propeptide, active MMP-2
was exposed to 60Gy. No loss of MMP-2 activity was measured
confirming that radiation did not degrade the active MMP-2
(Figure 5B).
Table 2 Effect of Matrigel irradiation on the invasiveness of MDA-MB-
231 cells
No.
Dose
(Gy) Conditions
Average number
of cells migrating
through
Matrigel (s.d.)
a
1 0 No irradiation 6.3 (±2.3)
2 20 Invasion chamber irradiated without PBS 24.0 (±9.6)*
3 20 Invasion chamber irradiated with PBS 54.0 (±13.0)*
4 0 PBS was removed after irradiation of
Matrigel and then added to new
non-irradiated chambers before
cells plating
57.0 (± 28.6)*
PBS¼phosphate-buffered saline; s.d.¼standard deviation. Invasion chambers were
treated as indicated. MDA-MB-231 cells (1 10
4) were added after irradiation of the
invasion chambers and incubated for 6h in MEM 0.1% BSA. The same volume of PBS
was added to the other invasion chambers (condition nos. 1, 2 and 4) before cells
plating. *n¼3. Student’s-t test: condition no. 1 vs 2, P¼0.003; condition no. 1 vs 3,
P¼0.026; conditions no. 1 vs 4, P¼0.023.
aAverage number of invasive cells
observed per microscope field.
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Figure 3 A matrix metalloproteinase (MMP)-2 inhibitor or an anti-
membrane type 1 matrix metalloproteinase (MT1-MMP) antibody
prevented radiation enhancement of MDA-MB-231 breast cancer cell
invasion. MDA-MB-231 cancer cells were mixed with either the MMP-2
inhibitor (2R)-[(4-biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropiona-
mide at 0.1mM, or an anti-MT1-MMP antibody (20mgml
 1) before plating
in the invasion chamber which was previously irradiated at 20Gy.*n¼3,
Po0.05.
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After breast-conserving surgery, 39–63% of patients have addi-
tional malignant foci scattered throughout the breast (Lagios et al,
1981; Holland et al, 1985). Radiation therapy after surgery consists
typically of irradiation of the whole breast with 50–60Gy,
delivered over 6 weeks. However, the radiation dose is not
calculated to eliminate all residual cancer cells. Rather, the
radiation dose is calculated to optimise the long-term results with
minimal complications (Coles et al, 2005). The overall aim of this
study was to determine whether ionising radiation could increase
the invasion ability of breast cancer cells.
Radiation enhancement of cancer cell invasiveness has already
been reported for other cancers. In vitro irradiation of human
glioma cells increased the expression of MMP-2 and enhanced
their invasiveness (Wild-Bode et al, 2001; Park et al, 2006; Zhai
et al, 2006). Sublethal in vitro irradiation of rat 9L glioma cells
resulted in the formation of a greater number of tumour satellites
after injection of these irradiated cells into the striatum of rat
brain. The ability of radiation to increase the expression of some
MMPs and the invasiveness of cancer cells have also been reported
for pancreatic cancer cells (Qian et al, 2002; Ohuchida et al, 2004),
melanoma cells (Kaliski et al, 2005), rectal carcinoma cells (Speake
et al, 2005), colon carcinoma cells and osteosarcoma cells (Wang
et al, 2000).
Cancer cells in the breast are surrounded by the basement
membrane, which plays an important role in regulating the
expression of numerous genes. In this study, we wanted to
determine whether irradiation of Matrigel (a reconstituted base-
ment membrane) could modify the invasive behaviour of breast
cancer cells.
Using invasion chambers, we have demonstrated that in vitro
irradiation of Matrigel at a dose as low as 5Gy before cells plating
enhanced the invasiveness of the highly metastatic MDA-MB-231
breast cancer cells. This radiation enhancement of invasion was
associated with the upregulation of pro-invasive gene MMP-2.
Indeed, irradiation of Matrigel before plating the cancer cells
resulted in an enhancement of proMMP-2 secreted from the two
breast cancer cell lines tested in the culture media, as detected
using a zymography gel. This enhancement was associated with an
increase of MMP-2 mRNA in both cell lines, as quantified by real-
time PCR. Supporting the role of MMP-2, radiation enhancement
of breast cancer cell invasion was prevented by an MMP-2
inhibitor. These results support the importance of the interactions
between breast cancer cells and irradiated Matrigel for the
expression of MMP-2.
MT1-MMP and TIMP-2 are required for the conversion of
inactive proMMP-2 into active MMP-2. The activation intermedi-
ate of MMP-2 matures after binding to avb3 integrin which is
localised at the cancer cell surface and concentrated at the
migrating front (Brooks et al, 1996). Irradiated Matrigel increased
the expression of both MT1-MMP and TIMP-2, as measured by
real-time PCR, and increased MMP-2 activity on the surface of
MDA-MB-231 cells. Supporting the role of MT1-MMP, the
radiation enhancement of MDA-MB-231 cell invasion was
prevented by mixing the cancer cells with an anti-MT1-MMP
antibody before plating in the irradiated invasion chamber.
Conversely, no enhancement of invasiveness was observed with
the low metastatic MCF-7 cell line. This latter result supports the
concept that radiation did not create ‘holes’ in Matrigel, which
would facilitate the migration of breast cancer cells. The inability
of radiation to enhance the invasion of MCF-7 cells was associated
with the absence of MT1-MMP expression, which is required to
activate proMMP-2. The MCF-7 cells do not also express the avb3
integrin (Deryugina et al, 1996) and consequently no MMP-2
activity was detected on surface of this breast cancer cell line.
These results suggest that the expression of MT1-MMP is required
for the enhancement of breast cancer cell invasion induced by
irradiating the Matrigel.
The radiation enhancement of breast cancer cell invasion
reported in this study could be related to two pathways. The
stimulation of the expression of various MMPs by damaged
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Figure 5 Inability of ionising radiation to directly activate the proMMP-2. (A) ProMMP-2 obtained from Calbiochem was irradiated at 20Gy. As positive
control, proMMP-2 was activated by p-aminophenylmercuric acetate (APMA). (B) Active MMP-2 was irradiated at 60Gy. The level of matrix
metalloproteinase (MMP) activity was determined using the fluorogenic peptide MMP Substrate III. *n¼6, Po0.05.
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Figure 4 Matrix metalloproteinase (MMP)-2 activity on MDA-MB-231
and MCF-7 cells plated on irradiated Matrigel. Matrigel was irradiated at 0
or 20Gy and the MDA-MB-231 or MCF-7 cells were plated and incubated
for 18h at 371C. Then the MEM 0.1% BSA was replaced by the enzymatic
buffer A and the MMP-2 activity was measured by adding the fluorogenic
peptide MMP Substrate III. (1) MDA-MB-231 cells and 0Gy; (2) MDA-MB-
231 cells and 20Gy; (3) MCF-7 and 0Gy and (4) MCF-7 and 20Gy. *n¼3,
Po0.05.
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healing (Gillard et al, 2004). Following damage to basement
membrane by chemical or physical agents, the production of
MMPs by fibroblasts is stimulated resulting in the remoulding and
the restoration of basement membrane. The stimulation of MMPs
expression is related to the following mechanisms. Basement
membrane stores pro-invasive factors such as IGF, EGF and bFGF.
These growth factors can be released by agents, which damage the
basement membrane. Once released, they can stimulate the
expression of MMP-2 and other MMPs (Mira et al, 1999; Zhang
and Brodt 2003; Lee et al, 2004). Our results support the idea that
the radiation enhancement of cancer cell invasion was related to
the release of pro-invasive factors stored in the Matrigel. Indeed,
we have shown that the transfer of conditioned PBS, which was
covering the Matrigel during the irradiation, to new non-irradiated
invasion chambers resulted in an eightfold increase of MDA-MB-
231 cells invasiveness.
An alternative explanation might be that basement membrane is
a source of matrikines, which can be unmasked after limited
proteolysis or cleavage by free radicals, as generated by ionising
radiation. In an adult organism in the resting state, there is little
MMP expression and activity (Bosman and Stamenkovic 2003).
However, basement membrane fragments or matrikines unmasked
by tissue injury can upregulate the expression of MMPs. For
example, the g2 subunit DIII fragment of laminin-5 can bind to the
cell surface of MDA-MB-231 breast cancer cells and upregulate the
expression of MMP-2 and -9 resulting in an increase migratory
activity (Schenk et al, 2003). The involvement of these two
mechanisms in radiation enhancement of cancer cell invasion
deserves to be tested in subsequent studies.
Radiotherapy is an efficient modality to treat malignant breast
tumours and other types of solid tumours. However, the present
study and previous reports published by other teams demonstrate
that radiation can also increase the invasion capacity of cancer
cells. To improve the efficacy of radiotherapy, this phenomenon
must be further studied to elaborate therapeutic modalities to
prevent radiation enhancement of cancer cell invasion.
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